Get the Stockscreener App
23.81
0.00%
0.00
Iambic Therapeutics, Inc. Common Stock stock is traded at $23.81, with a volume of 2.94M.
It is up +0.00% in the last 24 hours and up +0.00% over the past month.
See More
Previous Close:
$0.00
Open:
$19.31
24h Volume:
2.94M
Relative Volume:
1.00
Market Cap:
$1.13B
Revenue:
Net Income/Loss:
P/E Ratio:
-
EPS:
-
Net Cash Flow:
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$19.31
$25.00
52-Week Range:
$19.31
$25.00
Iambic Therapeutics, Inc. Common Stock Stock (IAM) Company Profile
Name
Iambic Therapeutics, Inc. Common Stock
Sector
Industry
Phone
-
Address
-
Compare IAM vs VRTX, MRNA, REGN, ARGX, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IAM
Iambic Therapeutics, Inc. Common Stock
|
23.81 | 1.13B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
499.74 | 126.66B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
218.01 | 87.04B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
790.74 | 81.41B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
819.14 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
369.06 | 41.75B | 5.76B | 514.49M | 1.10B | 4.4813 |
Iambic Therapeutics, Inc. Common Stock Stock (IAM) Latest News
Iambic Therapeutics CFO Michael Secora Granted RSUs and Stock Options on October 14, 2026 - Kalkine Media
Form 4 Iambic Therapeutics: Michael Secora (CFO & Chief Corp Dev Ofcr) For: 14 October - Investing.com India
Wilson Sonsini Advises Iambic Therapeutics on $150 Million Initial Public Offering - Wilson Sonsini
Total common shares outstanding of Iambic Therapeutics, Inc. – BOATS:IAM - TradingView
IAM SEC FilingsIambic Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance Australia
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
Rachlin Evan Lockwood Reports Initial Indirect Ownership in Iambic Therapeutics via Ascenta Capital - Kalkine Media
Iambic Therapeutics prices IPO at $16 per share to raise $150 million - scanx.trade
Iambic Therapeutics prices IPO at $16 per share - Investing.com
Articles from Iambic Therapeutics, Inc. - FinancialContent
Iambic Announces Pricing of Initial Public Offering - Business Wire
Iambic Therapeutics, Inc. has completed an IPO in the amount of $150 million. - www.marketscreener.com
Iambic Therapeutics Files to List Common Stock on Nasdaq Exchange - Kalkine Media
Diluted net income available to common stockholders of IAMBIC THERAPEUTICS INC – NASDAQ:IAM - TradingView
IAMBIC THERAPEUTICS INC Statistics – NASDAQ:IAM - TradingView
NVIDIA-Backed Iambic Therapeutics Files for IPO - Digital Health News
Iambic Therapeutics, Inc. has filed an IPO in the amount of $100 million. - www.marketscreener.com
Iambic Therapeutics, Inc. Common Stock Stock (IAM) Financials Data
There is no financial data for Iambic Therapeutics, Inc. Common Stock (IAM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
6.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):